🧠 AI clinical summary is being generated for this article and will appear shortly.
Source: MHRA · Read original ↗
The Commission on Human Medicines (CHM) has temporarily restricted use of the IXCHIQ Chikungunya vaccine in people aged 65 years and over following very rare fatal reactions reported globally. This is a precautionary measure…
This content is sourced from MHRA and reproduced for clinical reference. ClinicalIQ does not alter source content.